scholarly journals Proliferating NG2-Cell-Dependent Angiogenesis and Scar Formation Alter Axon Growth and Functional Recovery After Spinal Cord Injury in Mice

2017 ◽  
Vol 38 (6) ◽  
pp. 1366-1382 ◽  
Author(s):  
Zoe C. Hesp ◽  
Rim Y. Yoseph ◽  
Ryusuke Suzuki ◽  
Peter Jukkola ◽  
Claire Wilson ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Functional Recovery ◽  
Axon Growth ◽  
Scar Formation ◽  
Cord Injury

scholarly journals Combined Treatment with Fasudil and Menthol Improves Functional Recovery in Rat Spinal Cord Injury Model

Biomedicines ◽  
2020 ◽  
Vol 8 (8) ◽  
pp. 258
Author(s):  
JeongHoon Kim ◽  
Hari Prasad Joshi ◽  
Kyoung-Tae Kim ◽  
Yi Young Kim ◽  
Keundong Yeo ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Functional Recovery ◽  
Combined Treatment ◽  
Scar Formation ◽  
Sprague Dawley ◽  
Static Compression ◽  
Cord Injury ◽  
Fibrotic Scar ◽  
Spinal Cord Dysfunction

Neuroprotective measures by preventing secondary spinal cord injury (SCI) are one of the main strategies for repairing an injured spinal cord. Fasudil and menthol may be potent neuroprotective agents, which act by inhibiting a rho-associated protein kinase (ROCK) and suppressing the inflammatory response, respectively. We hypothesized that combined treatment of fasudil and menthol could improve functional recovery by decreasing inflammation, apoptosis, and glial scar formation. We tested our hypothesis by administering fasudil and menthol intraperitoneally (i.p.) to female Sprague Dawley rats after moderate static compression (35 g of impounder for 5 min) of T10 spinal cord. The rats were randomly divided into five experimental groups: (i) sham animals received laminectomy alone, (ii) injured (SCI) and untreated (saline 0.2 mL/day, i.p.) rats, (iii) injured (SCI) rats treated with fasudil (10 mg/kg/day, i.p.) for two weeks, (iv) injured (SCI) rats treated with menthol (10 mg/kg/day, i.p.) for twoweeks, (v) injured (SCI) rats treated with fasudil (5 mg/kg/day, i.p.) and menthol (10 mg/kg/day, i.p.) for two weeks. Compared to single treatment groups, combined treatment of fasudil and menthol demonstrated significant functional recovery and pain amelioration, which, thereby, significantly reduced inflammation, apoptosis, and glial/fibrotic scar formation. Therefore, combined treatment of fasudil and menthol may provide effective amelioration of spinal cord dysfunction by a synergistic effect of fasudil and menthol.

Wnt-Ryk Signaling Mediates Axon Growth Inhibition and Limits Functional Recovery after Spinal Cord Injury

2009 ◽  
Vol 26 (7) ◽  
pp. 955-964 ◽  
Author(s):  
Tomohiro Miyashita ◽  
Masao Koda ◽  
Keiko Kitajo ◽  
Masashi Yamazaki ◽  
Kazuhisa Takahashi ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Growth Inhibition ◽  
Functional Recovery ◽  
Axon Growth ◽  
Cord Injury

scholarly journals Astrocytic CCAAT/Enhancer-Binding Protein Delta Contributes to Glial Scar Formation and Impairs Functional Recovery After Spinal Cord Injury

2015 ◽  
Vol 53 (9) ◽  
pp. 5912-5927 ◽  
Author(s):  
Shao-Ming Wang ◽  
Jung-Yu C. Hsu ◽  
Chiung-Yuan Ko ◽  
Nai-En Chiu ◽  
Wai-Ming Kan ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Functional Recovery ◽  
Binding Protein ◽  
Glial Scar ◽  
Scar Formation ◽  
Enhancer Binding Protein ◽  
Cord Injury ◽  
Ccaat Enhancer Binding Protein

182 Acute Putrescine Supplementation With Schwann Cell Transplantation Improves Sensory and Serotonergic Axon Growth and Functional Recovery in Spinal Cord Injury

Neurosurgery ◽  
2015 ◽  
Vol 62 ◽  
pp. 226-227 ◽  
Author(s):  
Bryan Lorgulescu ◽  
Samik Patel ◽  
Jack Louro ◽  
Christrian Andrade ◽  
Andre Sanchez ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Schwann Cell ◽  
Cell Transplantation ◽  
Functional Recovery ◽  
Axon Growth ◽  
Cord Injury

scholarly journals GSK-3 Inhibitor Promotes Neuronal Cell Regeneration and Functional Recovery in a Rat Model of Spinal Cord Injury

2019 ◽  
Vol 2019 ◽  
pp. 1-8 ◽  
Author(s):  
Fei Lei ◽  
Wen He ◽  
Xinggui Tian ◽  
Qingzhong Zhou ◽  
Lipeng Zheng ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Functional Recovery ◽  
Glycogen Synthase ◽  
Neuronal Cell ◽  
Axon Growth ◽  
Competitive Inhibitor ◽  
Lower Limbs ◽  
Cell Regeneration ◽  
Cord Injury

The reparative process following spinal cord injury (SCI) is extremely complicated. Cells in the microenvironment express multiple inhibitory factors that affect axonal regeneration over a prolonged period of time. The axon growth inhibitory factor glycogen synthase kinase-3 (GSK-3) is an important factor during these processes. TDZD-8 (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) is the most effective and specific non-ATP-competitive inhibitor of GSK-3. Here, we show that administering TDZD-8 after SCI was associated with significantly inhibited neuronal apoptosis, upregulated GAP-43 expression, increased density of cortical spinal tract fibers around areas of injury, and increased Basso, Beattie, and Bresnahan (BBB) scores in the lower limbs. These findings support the notion that GSK-3 inhibitors promote neuronal cell regeneration and lower limb functional recovery.

scholarly journals The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury

Biomaterials ◽  
2014 ◽  
Vol 35 (16) ◽  
pp. 4610-4626 ◽  
Author(s):  
Yosuke Ohtake ◽  
Dongsun Park ◽  
P.M. Abdul-Muneer ◽  
Hui Li ◽  
Bin Xu ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Functional Recovery ◽  
Axon Growth ◽  
Antagonist Peptides ◽  
Cord Injury

Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus

2015 ◽  
Vol 26 (2) ◽  
Author(s):  
Haruo Kanno ◽  
Damien D. Pearse ◽  
Hiroshi Ozawa ◽  
Eiji Itoi ◽  
Mary Bartlett Bunge
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Functional Recovery ◽  
Axonal Regeneration ◽  
Therapeutic Strategy ◽  
Glial Scar ◽  
Scar Formation ◽  
Tissue Loss ◽  
Injured Spinal Cord ◽  
Cord Injury

AbstractTransplantation of Schwann cells (SCs) is a promising therapeutic strategy for spinal cord repair. The introduction of SCs into the injured spinal cord has been shown to reduce tissue loss, promote axonal regeneration, and facilitate myelination of axons for improved sensorimotor function. The pathology of spinal cord injury (SCI) comprises multiple processes characterized by extensive cell death, development of a milieu inhibitory to growth, and glial scar formation, which together limits axonal regeneration. Many studies have suggested that significant functional recovery following SCI will not be possible with a single therapeutic strategy. The use of additional approaches with SC transplantation may be needed for successful axonal regeneration and sufficient functional recovery after SCI. An example of such a combination strategy with SC transplantation has been the complementary administration of neuroprotective agents/growth factors, which improves the effect of SCs after SCI. Suspension of SCs in bioactive matrices can also enhance transplanted SC survival and increase their capacity for supporting axonal regeneration in the injured spinal cord. Inhibition of glial scar formation produces a more permissive interface between the SC transplant and host spinal cord for axonal growth. Co-transplantation of SCs and other types of cells such as olfactory ensheathing cells, bone marrow mesenchymal stromal cells, and neural stem cells can be a more effective therapy than transplantation of SCs alone following SCI. This article reviews some of the evidence supporting the combination of SC transplantation with additional strategies for SCI repair and presents a prospectus for achieving better outcomes for persons with SCI.

Sign in / Sign up

Export Citation Format

Share Document